GSK PLC (GSK)
41.26
+0.36
(+0.87%)
USD |
NYSE |
Apr 26, 14:09
GSK Revenue (Annual): 37.74B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 37.74B |
| December 31, 2022 | 36.31B |
| December 31, 2021 | 33.98B |
| December 31, 2020 | 31.26B |
| December 31, 2019 | 43.10B |
| December 31, 2018 | 41.12B |
| December 31, 2017 | 38.98B |
| December 31, 2016 | 37.79B |
| December 31, 2015 | 36.56B |
| December 31, 2014 | 37.92B |
| December 31, 2013 | 41.47B |
| December 31, 2012 | 41.88B |
| December 31, 2011 | 43.92B |
| December 31, 2010 | 43.77B |
| December 31, 2009 | 44.43B |
| December 31, 2008 | 45.04B |
| December 31, 2007 | 45.51B |
| December 31, 2006 | 42.80B |
| December 31, 2005 | 39.40B |
| December 31, 2004 | 36.61B |
| December 31, 2003 | 35.02B |
| Date | Value |
|---|---|
| December 31, 2002 | 31.88B |
| December 31, 2001 | 29.58B |
| December 31, 2000 | 27.40B |
| December 31, 1999 | 13.74B |
| December 31, 1998 | 13.23B |
| December 31, 1997 | 13.07B |
| December 31, 1996 | 13.03B |
| December 31, 1995 | 16.56B |
| June 30, 1995 | 10.23B |
| June 30, 1994 | 8.465B |
| June 30, 1993 | 8.013B |
| June 30, 1992 | 7.205B |
| June 30, 1991 | 6.303B |
| June 30, 1990 | 5.173B |
| June 30, 1989 | 4.411B |
| June 30, 1988 | 3.611B |
| June 30, 1987 | 2.655B |
| June 30, 1986 | 2.058B |
| June 30, 1985 | 1.450B |
| June 30, 1984 | 1.329B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
31.26B
Minimum
2020
43.10B
Maximum
2019
36.48B
Average
36.31B
Median
2022
Revenue (Annual) Benchmarks
| AstraZeneca PLC | 45.81B |
| Haleon PLC | 14.06B |
| Novo Nordisk A/S | 33.72B |
| Pfizer Inc | 58.50B |
| Sanofi SA | 50.28B |